Technical Report Pathology Trauma
Does an antibiotic stewardship programme reduce in-hospital mortality in adults with type 2 diabetes? A case series

Does an antibiotic stewardship programme reduce in-hospital mortality in adults with type 2 diabetes? A case series

Authors

Lucas Tanaka

Lucas Tanaka

Mayo Clinic, Russia

Corresponding
Adam Dubois

Adam Dubois

Mayo Clinic, Somalia

Hugo Haddad

Hugo Haddad

Charité Berlin, Tunisia

Mariam Rossi

Mariam Rossi

Mayo Clinic, Northern Mariana Islands

Mariam Zhang

Mariam Zhang

Toronto General Hospital, Malawi

Published

May 28, 2026

Paper ID

PAP-000044

Status

Published

DOI

10.65712/tmj.test000302

Does an antibiotic stewardship programme reduce in-hospital mortality in adults with type 2 diabetes? A case series

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Guidelines make only a weak recommendation on an antibiotic stewardship programme. Methods: The primary outcome was in-hospital mortality, assessed blind to allocation. Results: 1449 participants were included (median age 75 years). in-hospital mortality occurred in 5% of the intervention group versus 26% of controls. Conclusion: Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial.

Introduction

Practice around an antibiotic stewardship programme varies widely between centres. Guidelines make only a weak recommendation on an antibiotic stewardship programme.

Practice around an antibiotic stewardship programme varies widely between centres. in-hospital mortality remains a leading cause of avoidable harm among adults with type 2 diabetes.

Discussion

Strengths include the sample size and blinded outcome assessment. Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Strengths include the sample size and blinded outcome assessment. Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.

Implementation will depend on staffing, cost and local protocols. These findings suggest that an antibiotic stewardship programme is associated with better in-hospital mortality in adults with type 2 diabetes.

These findings suggest that an antibiotic stewardship programme is associated with better in-hospital mortality in adults with type 2 diabetes. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.

Conclusions

An antibiotic stewardship programme is a reasonable option for adults with type 2 diabetes to improve in-hospital mortality.

References

1. Dubois C, Okafor D, et al. Frailty screening and post-operative delirium. Diabetes Care. 2008;106(7):647-1776.

2. Novak G, Schmidt D, et al. High-flow nasal oxygen and length of stay. BMJ. 2008;341(3):231-1479.

3. Novak M, Nakamura Z, et al. SGLT2 inhibitors and length of stay. N Engl J Med. 2024;186(2):669-1209.

4. Mueller Z, Andersen U, et al. Early enteral nutrition and glycaemic control. Lancet. 2023;113(9):442-1295.

5. Haddad E, Ahmed I, et al. Frailty screening and 30-day readmission. Crit Care Med. 2025;122(11):306-1343.

Appendices

Ethics approval: IRB-2962.

Materials and Methods

Eligible participants were adults with type 2 diabetes.

Analyses were adjusted for age, sex and baseline severity. We conducted a case series across 3 centres between 2018 and 2023.

Missing data were handled with multiple imputation. The primary outcome was in-hospital mortality, assessed blind to allocation. Eligible participants were adults with type 2 diabetes. Analyses were adjusted for age, sex and baseline severity.

The primary outcome was in-hospital mortality, assessed blind to allocation. Eligible participants were adults with type 2 diabetes. Analyses were adjusted for age, sex and baseline severity.

Results

2137 participants were included (median age 46 years). 1094 participants were included (median age 80 years).

GroupnEventsRate %
Centre A41163.4
Intervention406337.4
Intervention6453426.2
Age ≥ 656736226.4
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Trend in in-hospital mortality
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Trend in in-hospital mortality
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

The adjusted odds ratio was 0.62 (95% CI 0.31 to 0.91). The adjusted odds ratio was 0.92 (95% CI 0.44 to 0.92). Serious adverse events were rare and similar between groups.